Page last updated: 2024-12-05

1,2-dibromo-3-chloropropane

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

## 1,2-Dibromo-3-chloropropane (DBCP)

**1,2-Dibromo-3-chloropropane (DBCP)** is a **colorless, volatile liquid** with a **sweet odor**. It is a **halogenated alkane**, meaning it contains bromine and chlorine atoms attached to a chain of carbon atoms.

**Historically, DBCP was used as a soil fumigant to control nematodes and other pests.** However, it was **banned in many countries** in the 1970s and 1980s due to its **high toxicity and carcinogenic properties**.

**Importance for research:**

Despite its ban, DBCP continues to be of interest in research due to its:

* **Toxicological significance:** Research focuses on understanding its **mechanisms of toxicity**, particularly its **carcinogenicity** and effects on the **reproductive system**. This includes studying its interactions with DNA and its potential to induce mutations.
* **Environmental impact:** Research investigates the **persistence and bioaccumulation** of DBCP in the environment, as well as its **fate and transport** in soil and water systems.
* **Historical perspective:** DBCP provides a **cautionary tale** regarding the potential **unforeseen consequences** of using synthetic chemicals. Its story highlights the importance of thorough **risk assessments** and **long-term monitoring** before introducing new chemicals into the environment.
* **Analytical chemistry:** DBCP can serve as a **model compound** for developing and validating **analytical methods** for detecting and quantifying other volatile organic compounds.
* **Bioremediation:** Research explores the use of **microorganisms** to break down DBCP in contaminated soil and water, potentially leading to new bioremediation strategies.

**It is important to note that while DBCP is banned in many countries, it may still be present in the environment due to past use and potential illegal production.** Therefore, understanding its properties and its impact on human health and the environment remains crucial.

**Safety precautions:**

* DBCP is highly toxic and should be handled with extreme caution.
* It is important to wear appropriate personal protective equipment when working with or around DBCP.
* Never handle DBCP without proper training and safety protocols.

1,2-dibromo-3-chloropropane: RN given refers to cpd with specified locants for bromine & chlorine moieties [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID7280
CHEMBL ID1331743
CHEBI ID34044
SCHEMBL ID82591
MeSH IDM0050445

Synonyms (101)

Synonym
AKOS015836028
bbc 12
propane,2-dibromo-3-chloro-
dibromochloropropane
dibromchlorpropan
nci-c00500
sd 1897
nemazon
nsc-1512
nemafume
1,2-dibromo-3-cloro-propano
dbcp
nemabrom
nemapaz
1,2-dibromo-3-chloropropane
3-chloro-1,2-dibromopropane
fumazone 86
nemanax
1,2-dibroom-3-chloorpropaan
nemagon 20g
96-12-8
nemagon
fumazone
fumazone 86e
os 1897
nemagon 90
nemagon 20
nemaset
fumagon
nemagon soil fumigant
wln: g1ye1e
1-chloro-2,3-dibromopropane
nsc1512
1,2-dibrom-3-chlor-propan
propane, 1,2-dibromo-3-chloro-
inchi=1/c3h5br2cl/c4-1-3(5)2-6/h3h,1-2h
NCGC00090684-01
oxy dbcp
nemagon 206
bbcp
1,2-dibroom-3-chloorpropaan [dutch]
un2872
nematocide em 15.1
1,2-dibrom-3-chlor-propan [german]
nematocide em 12.1
rcra waste number u066
ai3-18445
1,2-dibromo-3-cloro-propano [italian]
caswell no. 287
epa pesticide chemical code 011301
nemanex
2,3-dibromo-1-chloropropane
nematocide
durham nematicode em 17.1
ccris 215
gro-tone nematode granular
fumazon 86
nsc 1512
einecs 202-479-3
dibromchlorpropan [german]
brn 1732077
nemagone
propane, 1-chloro-2,3-dibromo-
hsdb 1629
rcra waste no. u066
1,2-dibromo-3-chloropropane, 97%
1,2-dibromo-3-chloropropane (dbcp)
smr000677929
MLS001061196
1,2-dibromopropyl chloride
3-chloropropylene bromide
C0806
A845549
NCGC00090684-02
HMS3039L07
propane, dibromochloro-
67708-83-2
dtxcid50413
tox21_200382
cas-96-12-8
NCGC00257936-01
dtxsid3020413 ,
dibromochloropropane [un2872] [poison]
3-01-00-00250 (beilstein handbook reference)
96k0fd4803 ,
unii-96k0fd4803
ec 202-479-3
FT-0606354
dibromochloropropane [mi]
1,2-dibromo-3-chloropropane [hsdb]
1,2-dibromo-3-chloropropane [iarc]
dibromochloropropane [mart.]
SCHEMBL82591
CHEMBL1331743
CHEBI:34044 ,
clch2chbrch2br
mfcd00039365
1,2-dibromo-3-chloropropane, pestanal(r), analytical standard
1,2-dibromo-3-chloropropane 2000 microg/ml in methanol
Q161465
D89298

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" The dibromomonochlorinated analogue 1,3-dibromo-2-chloropropane was less organ toxic than DBCP and 1,2,3-tribromopropane, but induced more organ damage than the dichloromonobrominated analogues 1-bromo-2,3-dichloropropane and 1,3-dichloro-2-bromopropane."( Effect of bromine and chlorine positioning in the induction of renal and testicular toxicity by halogenated propanes.
Brunborg, G; Dahl, JE; Dybing, E; Holme, JA; Låg, M; Nelson, SD; Omichinski, JG; Søderlund, EJ,
)
0.13
"This study was set to determine if there is a correlation between the general toxic effect and the gonadotoxic effect of DBCP on male rats."( The effects of 1,2-dibromo-3-chloropropane (DBCP) on general toxicity and gonadotoxicity in rats.
Kaplanski, J; Potashnik, G; Shemi, D; Sod-Moriah, UA; Waksman, J,
)
0.48
" the Leydig cell, is a potential site for the primary toxic effects of these agents in the rat testis."( Gonadotoxic effects of 2-hexanone and 1,2-dibromo-3-chloropropane on the enzymatic activity of rat testicular 17 alpha-hydroxylase/C17,20-lyase.
Ganjam, VK; Kelce, WR; Raisbeck, MF, 1990
)
0.55
" One group of treated animals was killed 1 to 3 days afterward to compare the dose and time relationships of the acute toxic response of neonatal and weanling male rats to DBCP and another group at approximate sexual maturity (approximately 120 days of age) to detect residual toxic effects resulting from acute exposure."( Initial and residual toxicity following acute exposure of developing male rats to dibromochloropropane.
Greenwell, A; Harrington, F; Kluwe, WM; Weber, H, 1985
)
0.27
" Single-treatment, subcutaneous LD50 values for DBCP were 102 mg/kg in non-pretreated and 128 mg/kg in phenobarbital pretreated rats."( Chemical modulation of 1,2-dibromo-3-chloropropane toxicity.
Kluwe, WM,
)
0.44
" Organ toxicity studies showed that (S)-DBCP was slightly more renal toxic than (R)-DBCP but was not significantly more toxic than the racemate, and that no significant differences were observed in the extents of testicular necrosis and atrophy caused by either enantiomer or the racemate."( Comparative toxicity of (+)-(R)- and (-)-(S)-1,2-dibromo-3-chloropropane.
Dybing, E; Kouzi, SA; Meerman, JH; Nelson, SD; Søderlund, EJ, 1995
)
0.55
" While current animal models are available, understanding of the reproductive toxic effects on human fertility requires a more robust model system."( Assessing reproductive toxicity of two environmental toxicants with a novel in vitro human spermatogenic model.
Bradner, JM; Caudle, WM; Easley, CA; Hansen, JM; McEachin, ZT; Merritt, MM; Moser, A; Rickman, CA, 2015
)
0.42

Dosage Studied

ExcerptRelevanceReference
" The slopes of the dose-response curves (1."( Induction of unscheduled DNA synthesis in mouse germ cells following 1,2-dibromo-3-chloropropane (DBCP) exposure.
Lee, IP; Suzuki, K, 1979
)
0.49
" In one study, we observed unusual dose-response in lymphocyte chromosome aberration frequencies after exposure of mice to low doses of a chemical mixture (benzene, chloroprene, epichlorohydrin, and xylene)."( Cytogenetic assays in genotoxic studies: somatic cell effects of benzene and germinal cell effects of dibromochloropropane.
Au, WW; Cantelli-Forti, G; Hrelia, P; Legator, MS, 1990
)
0.28
" Dosing with 250 mg/kg azobenzene over 3 consecutive days led to an accumulation of micronucleated polychromatic erythrocytes."( Micronucleus induction by azobenzene and 1,2-dibromo-3-chloropropane in the rat: evaluation of a triple-dose protocol.
Gatehouse, DG; George, E; Wootton, AK,
)
0.4
" The proportion of sperm with abnormal tails also increased as DBCP dosage increased."( Measurement of semen quality, fertility, and reproductive hormones to assess dibromochloropropane (DBCP) effects in live rabbits.
Foote, RH; Schermerhorn, EC; Simkin, ME, 1986
)
0.27
"This study was designed to evaluate new protocols proposed for use as an initial screen or a dose-response test of an agent for adverse effects on male reproduction."( Assessment of procedures for screening agents for effects on male reproduction: effects of dibromochloropropane (DBCP) on the rat.
Amann, RP; Berndtson, WE, 1986
)
0.27
" After dosing for an interval at least equal to six times the duration of one cycle of the seminiferous epithelium, sperm from ejaculated semen or the cauda epididymidis can be evaluated for normalcy of morphology or function and should be used for artificial insemination of females to critically evaluate fertility."( Detection of alterations in testicular and epididymal function in laboratory animals.
Amann, RP, 1986
)
0.27
" Finally, a dose-response model suggested significant changes in sperm density at the short-term but more recently operated production site when more than 100 adjusted hours of exposure were exceeded, while the longer operated but longer closed facility demonstrated a significant impairment only when more than 1,000 adjusted hours of dibromochloropropane exposure were surpassed."( Dibromochloropropane and its effect on testicular function in man.
Joyner, RE; Lipshultz, LI; Milby, T; Ross, CE; Smith, R; Whorton, D, 1980
)
0.26
" (2) Exposure paradigms: extrapolating dosing in animals to exposures in humans becomes complex."( Reproductive toxicology: current and future directions.
Hoyer, PB, 2001
)
0.31
" However, since Inhibin B was only decreased at the end of the Dosing Phase and not at the Recovery Phase, when the onset of testicular pathology occurred, it is unclear if monitoring Inhibin B would provide sufficient advanced warning for the onset of testicular pathology."( Assessment of inhibin B as a biomarker of testicular injury following administration of carbendazim, cetrorelix, or 1,2-dibromo-3-chloropropane in Wistar han rats.
Her, LS; Knight, BL; Mineo, AM; Moffit, JS; Phillips, JA; Thibodeau, MS, 2013
)
0.6
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
organochlorine compoundAn organochlorine compound is a compound containing at least one carbon-chlorine bond.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (6)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency35.48130.003245.467312,589.2998AID2517
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency39.81070.011212.4002100.0000AID1030
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency54.09510.003041.611522,387.1992AID1159552
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency50.11870.001019.414170.9645AID588537
chromobox protein homolog 1Homo sapiens (human)Potency89.12510.006026.168889.1251AID540317
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency66.82420.000627.21521,122.0200AID651741
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (13)

Assay IDTitleYearJournalArticle
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1745845Primary qHTS for Inhibitors of ATXN expression
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (213)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990144 (67.61)18.7374
1990's46 (21.60)18.2507
2000's14 (6.57)29.6817
2010's7 (3.29)24.3611
2020's2 (0.94)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 33.51

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index33.51 (24.57)
Research Supply Index5.59 (2.92)
Research Growth Index4.11 (4.65)
Search Engine Demand Index47.76 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (33.51)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews28 (10.53%)6.00%
Case Studies1 (0.38%)4.05%
Observational0 (0.00%)0.25%
Other237 (89.10%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]